• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute , 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI Standards PDF

CSA C22.2 NO. 25-1966 (R2014)
CSA A371-94 (R1999)

CSA A371-94 (R1999)

$23.00 $47.00

CSA Z760-94 (R2001)

CSA Z760-94 (R2001)

$42.00 $84.00

CSA C22.2 NO. 601.1S1-94 (R1999)